{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Naltrexone: New Dosages and Uses for Pain and Inflammation
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify recent studies examining the beneficial effects of low-dose naltrexone in some inflammatory diseases.
- Describe the safety profile of low-dose naltrexone and how it compares to customary dosages.
- List the advantages of naltrexone over earlier opioid antagonists.
Disclosures
Dr. Swiden is a speaker for Amgen and BioHaven.
Lippincott CME Institute has identified and mitigated all relevant financial relationships. All other authors, planners, and staff have no relevant financial relationship with any ineligible organizations regarding this educational activity. The U.S. Food and Drug Administration has not approved the use of low-dose naltrexone as discussed in this article. Please consult the product's labeling for approved information.
Price:
$49.00
Credits:
- ANCC 2.0 CH / 2.0 APH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
- NM - BON 2.0 CH
- SC - BON 2.0 CH
- WV - BOERN 2.0 CH
Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: TPM0922
Published: Sep 2022
Expires: 9/5/2025
Required Passing Score: 8/10 (80%)
Categories:
Advanced Pharmacology Hours
,
Advanced Practice Nursing
,
Drug Therapy
,
Pain Management
,
Pharmacology
Specialties:
Advanced Practice Nursing,
Pain Management
Topics:
Naltrexone